Search with one or more keywords


This page gives you access to all the studies carried out by French researchers, identified on Covid-19.

To view other resources related to Covid-19, click here.


xml
XML

Export to XML

Please choose the format :

pdf
PDF

Export to PDF

Which version do you want to export ?

csv
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Covid-19 : 80 forms

Sorting of results :

Corange - Study of the seroprevalence of coronavirus in an Orange employee population

Head : GOUYET Thomas

Version 1
Overview

7

Last update : 05/06/2021

Corange - Study of the seroprevalence of coronavirus in an Orange employee population

Head : GOUYET Thomas

Main objective

The primary objective of the study is to determine serological status for coronavirus on a sample based on an Orange employee population.

Inclusion criteria

All Orange employees, volunteering to take part in the study. - Aged 18 years or over on the day of enrolment

CORhum - Morbidity-mortality of COVID-19 in patients with chronic rheumatic disorder treated with immunosuppressants

Head : LETAROUILLY Jean-Guillaume

Version 1
Overview

8

Last update : 05/05/2021

CORhum - Morbidity-mortality of COVID-19 in patients with chronic rheumatic disorder treated with immunosuppressants

Head : LETAROUILLY Jean-Guillaume

Main objective

Estimate morbidity-mortality associated with COVID-19 in patients with chronic rheumatic disorder (CRD) receiving immunosuppressants (IS).

Inclusion criteria

Patients with RA on csDMARD +/- bDMARD or tsDMARD +/- corticosteroid therapy fulfilling 2010 ACR/EULAR classification criteria? Patients with SpA receiving bDMARD or tsDMARD +/- csDMARD +/- non-steroidal anti-inflammatory drugs fulfilling ASAS classification criteria? Patients with SLE receiving hydroxychloroquine +/- csDMARD +/- corticosteroid therapy +/- bDMARD fulfilling 2019 ACR/EULAR classification criteria

COroFET - Clinical and laboratory epidemiological monitoring of pregnant women with evaluation of the obstetric, foetal and neonatal risk associated with SARS-CoV-2 during the COVID-19 pandemic– COroFET 

Head : DUBUCS Charlotte, IUCT-Oncopole Pathology Department

Version 1
Overview

9

Last update : 05/05/2021

COroFET - Clinical and laboratory epidemiological monitoring of pregnant women with evaluation of the obstetric, foetal and neonatal risk associated with SARS-CoV-2 during the COVID-19 pandemic– COroFET 

Head : DUBUCS Charlotte, IUCT-Oncopole Pathology Department

Main objective

In this situation in which data are crucial to understanding the effects of SARS-CoV-2 in the pregnant female population, our primary objective is to collect clinical and paraclinical data from a large sample of women recruited from our level 3 maternity unit, and to create biological and tissue collections with a view to responding to a series of questions, partly explained in the research programme, but which may also evolve as knowledge progresses.

Inclusion criteria

Adult females aged 18 years or over at the date of inclusion
Pregnant women giving birth at the Paule de Viguier maternity unit, Toulouse University Hospital, in the study, between April 2020 and April 2021, regardless of pregnancy outcome (live births, intrauterine foetal death, termination of pregnancy, i.e. miscarriages, medical termination of pregnancy) and term
Women having given their consent to take part in the study
Women registered with a social security scheme (including the state welfare scheme)

COV1APHP - Collection of blood samples from individuals having developed SARS CoV-2 infection

Head : Launay Odile

Version 1
Overview

10

Last update : 04/22/2021

COV1APHP - Collection of blood samples from individuals having developed SARS CoV-2 infection

Head : Launay Odile

Main objective

This study aims to develop prototype tests for the in vitro diagnostic serology of SARS-CoV-2

Inclusion criteria

Healthcare personnel or patient, having recovered from COVID-19
Individuals having developed typical symptoms of SARS-CoV-2, with a result confirmed by a PCR laboratory test on a nasopharyngeal swab, and with a blood sample taken at least 10 days after onset of symptoms
Adults
Individuals having been duly informed and signed the informed consent form
Affiliated with a French social security system

Cov-Activité - Implementation and effect of implementing physical activity program among older adults in hospitalized positive covid-19 older adults

Head : ROLLAND Yves

Version 1
Overview

11

Last update : 05/05/2021

Cov-Activité - Implementation and effect of implementing physical activity program among older adults in hospitalized positive covid-19 older adults

Head : ROLLAND Yves

Main objective

Describe the feasibility of an unsupervised physical activity exercise programme for adults aged 75 years and over, hospitalised in covid-19 unit

Inclusion criteria

75 years and over
COVID-19 positive on molecular diagnosis (PCR) or highly probable diagnosis by CT scan
Hospitalised in the geriatric post-emergency department (COVID unit), Rehabilitation Unit (Toulouse), Grenoble geriatric department and Guadeloupe University Hospital
Patient able to perform all tests

COVIDET - Evaluation of SARS-CoV-2 seroprevalence among prison inmates

Head : Mellon Guillaume

Version 1
Overview

12

Last update : 05/05/2021

COVIDET - Evaluation of SARS-CoV-2 seroprevalence among prison inmates

Head : Mellon Guillaume

Main objective

Evaluate the prevalence of SARS-CoV-2 infection among prison inmates in detention institutions in the Ile-de-France region, by measuring SARS-CoV-2 antibody levels in plasma

Inclusion criteria

Subjects fulfilling all of the following criteria will be included in the study:
o Female inmates on the lists provided by the detention institutions or male inmates randomly selected from the lists provided by the detention institutions.
o Aged 18 to 80 years.
o Freely given, informed consent form signed.

Please wait...

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05

View Edit Create here